Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3) [3]

Movement Disorders

Volumn 22, Issue 6, 2007, Pages 900-902

  Tackenberg, Björn ^a   Metz, Aline ^a   Unger, Marcus ^a   Schimke, Nicole ^a   Passow, Sebastian ^a   Hoeffken, Helmut ^a   Hoffmann, Georg F ^b   Müller, Ulrich ^c   Nolte, Dagmar ^c   Oertel, Wolfgang H ^a   Eggert, Karla ^a   Möller, Jens Carsten ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; BOTULINUM TOXIN A; LEVODOPA; PROPRANOLOL;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DYSTONIA; HUMAN; LETTER; LUMBAR PUNCTURE; MALE; PARKINSONISM; PRIORITY JOURNAL; RADIODIAGNOSIS; SCORING SYSTEM; STRIATONIGRAL DEGENERATION; X CHROMOSOME LINKED DISORDER;

BRAIN; CORPUS STRIATUM; HUMANS; PARKINSON DISEASE; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; X CHROMOSOME;

EID: 34249050089     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21462     Document Type: Letter

References (10)

1. Lee LV, Maranon E, Demaisip C, et al. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Parkinsonism Relat Disord 2002;9:29-38.
2. Nolte D, Niemann S, Müller U. Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc Natl Acad Sci 2003;100:10347-10352.
3. Goto S, Lee LV, Munoz EL, et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005;58:7-17.
4. Evidente VG, Advincula J, Esteban R, et al. Phenomenology of "Lubag" or X-linked dystonia-parkinsonism. Mov Disord 2002;17: 1271-1277.
5. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59:999-1005.
6. Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ. Grosset DG. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000; 15:692-698.
7. Asanuma K, Ma Y, Okulski J, et al. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 2005;64:347-349.
8. Boesch SM, Donnemiller E, Muller J, et al. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study. Mov Disord 2004;19:1320-1325.
9. Makino S, Kaji R, Ando S, et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 2007;80:393-406.
10. Stiasny-Kolster K, Möller JC, Zschocke J, et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 2004;19: 192-196.